Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myog

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • psimonkey

    Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myog

    Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis.

    Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K.

    Department of Veterinary Basic Sciences, Royal Veterinary College, London NW1 OTU, UK.

    Follistatin is known to antagonise the function of several members of the TGF-beta family of secreted signalling factors, including Myostatin, the most powerful inhibitor of muscle growth characterised to date. In this study, we compare the expression of Myostatin and Follistatin during chick development and show that they are expressed in the vicinity or in overlapping domains to suggest possible interaction during muscle development. We performed yeast and mammalian two-hybrid studies and show that Myostatin and Follistatin interact directly. We further show that single modules of the Follistatin protein cannot associate with Myostatin suggesting that the entire protein is required for the interaction. We analysed the interaction kinetics of the two proteins and found that Follistatin binds Myostatin with a high affinity of 5.84 x 10(-10) M. We next tested whether Follistatin suppresses Myostatin activity during muscle development. We confirmed our previous observation that treatment of chick limb buds with Myostatin results in a severe decrease in the expression of two key myogenic regulatory genes Pax-3 and MyoD. However, in the presence of Follistatin, the Myostatin-mediated inhibition of Pax-3 and MyoD expression is blocked. We additionally show that Myostatin inhibits terminal differentiation of muscle cells in high-density cell cultures of limb mesenchyme (micromass) and that Follistatin rescues muscle differentiation in a concentration-dependent manner. In summary, our data suggest that Follistatin antagonises Myostatin by direct protein interaction, which prevents Myostatin from executing its inhibitory effect on muscle development.
  • psimonkey

    #2
    ABSORPTION PROFILE AND HORMONAL INFLUENCES OF Fertilized EGG YOLK INGESTION
    IN THE HUMAN
    Colker. C. Peak Wellness, Inc. Greenwich, CT

    Fertile egg yolks contain significant concentrations of follistatin. In an
    effort to identify whether this orally ingested source of naturally
    occurring follistatin is actually absorbed and pharmacokinetically active in
    the human model, this study was undertaken. A male subject was chosen
    because the nornma1basline male physiology does not regularly contain any
    measurable concentration of follistatin. Follistatin-rich fertile egg yolk
    powder properly processed to preserve active follistatin (FolstaxanTM) was
    obtained (Celldyne Biopharma, San Antonio, TX). After initial blood draw and
    subsequential oral Folstaxan dosing, serum follistatin levels were
    qualitatively and quantitatively) measured as an indicator of absorption. In
    addition, since we know follistatin is a negative modulator of myostatin,
    serum myostatin levels were qualitatively and quantitatively measured as an
    indication of hormonal influence and thus true pharmacokinetic activity.
    Testing utilized purchased follistatin and myostatin standardized for
    verification. Confirmations were run by ELISA and quantitations by Liquid
    Chromatography Tandem Mass Spectrometer with third degree fragmentation
    (Expertox, Deer Park, TX). Results showed as predicted, a zero level of
    follistatin at baseline with a myostatin level of 46 pg/ml, 12 hours after
    FolstaxanTM dosing. Serum follistatin measured 57.1 pg/ml with a decline of
    myostatin to 34 pg/m1, 24 hours after the initial dosing, follistatin levels
    began to predictably drop from the time of initial dosing to 11.4 pg/ml. Yet
    myostatin continued to decline slightly with a 24-hour level of 31 pg/ml.
    These results clearly indicate that a fertile egg yolk powder properly
    processed to preserve active follistatin, when orally ingested, results in
    detectable serum follistatin. Furthermore, this resultant follistatin
    presence has significant pharmacokinetic activity is shown by the hormonal
    down regulation of serum follistatin.

    Comment

    • psimonkey

      #3

      Comment

      • psimonkey

        #4
        BioVendor R&D - BioVendor Research and Diagnostic Products is a developer and manufacturer of immunoassays, recombinant proteins, antibodies and endotoxin-removal products.

        Comment

        Working...